barbara_jones_story_klh7170-inline.jpg

Jones’ upbeat and positive spirit endeared her to clinical support staff members including senior research nurse Sylvia Paton (right). Jones continues to receive the experimental drug, ficlatuzumab, that was studied in the clinical trial.